BluePath Capital Management’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$301K Buy
2,069
+498
+32% +$73K 0.16% 119
2026
Q2
$230K Buy
+1,571
New +$229K 0.13% 121
2025
Q2
– Sell
-4,995
Closed -$851K – 92
2025
Q1
$851K Sell
4,995
-2,385
-32% -$399K 0.89% 25
2024
Q4
$1.17M Buy
7,380
+1,242
+20% +$212K 0.63% 40
2024
Q3
$1.06M Buy
6,138
+939
+18% +$159K 0.66% 29
2024
Q2
$857K Buy
5,199
+1,111
+27% +$182K 0.6% 36
2024
Q1
$663K Buy
4,088
+2,596
+174% +$407K 0.5% 38
2023
Q4
$224K Buy
1,492
+14
+0.9% +$2.07K 0.19% 98
2023
Q3
$216K Buy
+1,478
New +$226K 0.2% 94

Other funds holding PG

BluePath Capital Management's PG Position: Q3 2026 in Review

BluePath Capital Management increased its Procter & Gamble (PG) stake by 32% in Q3 2026, buying an estimated $73K and bringing the position to 2,069 shares worth $301K. The position accounts for 0.16% of the portfolio, ranked #119.

BluePath Capital Management first reported a position in PG in Q3 2023 and has held it in 9 quarters since. The position peaked at $1.17M in Q4 2024. 3,574 funds tracked by Wall St. Rank hold PG as of Q3 2026.

  • BluePath Capital Management held 2,069 shares of Procter & Gamble worth $301K as of Q3 2026.
  • BluePath Capital Management bought 498 Procter & Gamble shares in Q3 2026, an estimated $73K.
  • Procter & Gamble made up 0.16% of BluePath Capital Management's portfolio in Q3 2026, its #119 holding.
  • BluePath Capital Management first reported a position in Procter & Gamble in Q3 2023 and has held it in 9 quarters since.
  • BluePath Capital Management's Procter & Gamble position peaked at $1.17M in Q4 2024.
  • 3,574 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2026.

Based on BluePath Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.